SEC Comment Letter 0000000000-24-000736 to CITIUS ONCOLOGY, INC. (CTOR)

CITIUS ONCOLOGY, INC.
Date: Jan. 19, 2024 · CIK: 0001851484 · Accession: 0000000000-24-000736

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-41534

Date

January 19, 2024

Author

Taylor Zhang

Form

UPLOAD

Company

CITIUS ONCOLOGY, INC.

Letter

United States securities and exchange commission logo January 19, 2024 Taylor Zhang Chief Financial Officer TenX Keane Acquisition 420 Lexington Ave Suite 2446 New York, NY 10170 Re:TenX Keane Acquisition Schedule 14A Preliminary Proxy Statement Filed December 28, 2023 File No. 001-41534 Dear Taylor Zhang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tammara Fort, Esq.

Show Raw Text

United States securities and exchange commission logo
January 19, 2024
Taylor Zhang
Chief Financial Officer
TenX Keane Acquisition
420 Lexington Ave Suite 2446
New York, NY 10170
Re:TenX Keane Acquisition
Schedule 14A Preliminary Proxy Statement
Filed December 28, 2023
File No. 001-41534
Dear Taylor Zhang:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Tammara Fort, Esq.

SecProbe.io